DOYLESTOWN, Pa., Nov. 17, 2011 /PRNewswire/ -- ProPhase Labs (NASDAQ: PRPH), makers of Cold-EEZE Cold Remedy, a leader in over-the-counter (OTC) homeopathic cold remedies, is excited to announce that Cold-EEZE has been awarded the Parent Tested Parent Approved (PTPA) Winner's Seal of Approval. PTPA Media has North America's largest volunteer parent testing community, with over 40,000 parents. The seal of approval was awarded based on quality, effectiveness and value.
Cold-EEZE is the #1 pharmacist-recommended zinc cold remedy. Its proprietary zinc gluconate formula is clinically proven to safely and effectively reduce the duration and the severity of the symptoms of a common cold by nearly half (42%).
"This Seal of Approval reflects the high standards that we set for Cold-EEZE, and we are honored to receive this award," says Ted Karkus, Chairman and Chief Executive Officer of ProPhase Labs. "This recognition highlights the benefits and value that Cold-EEZE offers to families during the cough and cold season."Cold-EEZE was among many entries from across North America competing to earn the PTPA™ Seal. Independent parent volunteers evaluate these products in their own homes. Therefore, PTPA winners are chosen based on merit and consumer experience – not on commercial considerations. As a result, the PTPA Media™ Seal has quickly gained recognition as an international leader in certifying consumer products for quality, effectiveness and value. PTPA's CEO and founder, Sharon Vinderine, has appeared on over 40 morning shows as a reliable source for the latest and greatest in family products. The media and parents alike trust the collective opinion that PTPA Media represents. "At PTPA Media, we are proud to play a role in certifying innovative products that families can trust," says Vinderine. "When consumers search for our Seal of Approval on product packaging and web sites, they are essentially searching for validation from their peers. Their peers will have objectively tested and approved these products based on their performance in a real life environment. That type of resource for families is priceless."
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV